Topic Hub
15 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 15 of 15 clinical reviews.
Modafinil induces CYP3A4, the primary enzyme that metabolizes apixaban. This interaction may lower apixaban blood levels and reduce anticoagulant protection. Learn the mechanism, clinical significance, monitoring steps, and when to consider alternatives.
Read clinical reviewModafinil induces CYP3A4, which can lower atorvastatin blood levels and reduce statin efficacy. Learn the mechanism, clinical significance, monitoring plan, and alternative statin options.
Read clinical reviewModafinil (Provigil) reduces hormonal contraceptive efficacy through CYP3A4 induction. Learn the mechanism, clinical impact, FDA warnings, and backup contraception strategies.
Read clinical reviewClinical guide to the modafinil-bupropion drug interaction covering CYP enzyme effects, seizure threshold concerns, dose adjustments, and physician monitoring protocols.
Read clinical reviewA clinical deep-dive into the pharmacokinetic interaction between modafinil (Provigil) and finasteride, covering CYP3A4 induction, expected magnitude, monitoring, and practical dose-adjustment guidance.
Read clinical reviewIs it safe to take Provigil (modafinil) with metformin? A physician-reviewed guide covering CYP enzyme interactions, blood glucose effects, monitoring protocols, and dose-adjustment considerations.
Read clinical reviewCan you take Provigil with ibuprofen or naproxen? A clinician-reviewed breakdown of the modafinil-NSAID interaction, covering CYP metabolism, GI risk, renal concerns, and dose-adjustment guidance.
Read clinical reviewA physician-reviewed guide to the modafinil-prednisone drug interaction, covering CYP3A4 induction, reduced steroid exposure, glucose effects, and clinical monitoring.
Read clinical reviewBoard-reviewed guide to the modafinil-pregabalin drug interaction covering CYP pharmacokinetics, pharmacodynamic CNS effects, monitoring, dose adjustment, and patient counseling.
Read clinical reviewBoard-reviewed analysis of the modafinil-rosuvastatin drug interaction, covering CYP enzyme mechanisms, clinical severity, monitoring parameters, and when dose adjustment may be needed.
Read clinical reviewModafinil induces CYP3A4 and can lower simvastatin blood levels by up to 50%. Learn the mechanism, severity rating, dose adjustments, and monitoring steps from FDA labels and primary literature.
Read clinical reviewClinical review of modafinil interactions with SSRIs including sertraline and escitalopram. Covers CYP2C19 inhibition, serotonin syndrome risk, dose adjustment, and monitoring protocols.
Read clinical reviewA clinical deep-dive into the modafinil, diphenhydramine drug interaction, covering CYP enzyme effects, pharmacodynamic opposition, severity ratings, dose adjustments, and patient counseling.
Read clinical reviewA clinical review of the modafinil-levothyroxine drug interaction covering CYP3A4 induction, absorption timing, TSH monitoring, and dose-adjustment protocols.
Read clinical reviewModafinil (Provigil) and sildenafil share CYP3A4 metabolism. Learn the pharmacokinetic interaction, clinical severity, dose adjustments, and monitoring recommendations backed by FDA labeling and primary literature.
Read clinical review